Executive Team

Massive Bio's multidisciplinary team has in-depth oncology, clinical research, technology, services and commercial experience.

Selin Kurnaz
Selin Kurnaz, PhD
Lead-founder and CEO

After completing her PhD at the University of Michigan, receiving multiple engineering degrees, Selin spent more than a decade specializing in delivering revenue enhancement, margin optimization and capital efficiency improvements for Healthcare and Life Science companies. She started Massive Bio to bring the latest knowledge in cancer care to patients.

Dr. Arturo Loaiza-Bonilla, MD MSEd
Dr. Arturo Loaiza-Bonilla, MD
Co founder and Chief Medical Advisor

A dedicated practicing clinician, international speaker, and precision oncology expert with experience at Abramson Cancer Center of the University of Pennsylvania, University of Miami, Johns Hopkins and the National Institutes of Health. His interests include using innovative approaches to optimize clinical workflows and trial design, next-generation personalized molecular diagnostics, and the patient’s status in treatment decision making with Artificial Intelligence.

Cagatay Culcuoglu
Cagatay M. Culcuoglu, MBA
Co founder, COO and CTO

Leading operational strategy, global business initiatives, product, and technology development at Massive Bio, Mr. Culcuoglu has developed several products over the past 20 years for financial, media and health industries, co founding a few start-ups along the way. He holds an MBA degree from Pennsylvania State University and MA degree from University of Maastricht.

Jason L. Freedman
Dr. Jason L. Freedman, MD MSCE
Chief Pediatric Advisor

A Board-Certified Pediatric Oncologist, Dr. Freedman received his medical degree Magna Cum Laude from Upstate Medical University in Syracuse, NY. He served as Pediatric Chief Resident at Columbia University. Dr. Freedman completed fellowship training in Pediatric Hematology/Oncology at Children’s Hospital of Philadelphia, and earned a Master of Science in Clinical Epidemiology from the University of Pennsylvania.

Kristin Johnston
Kristin Johnston, RN
Chief Nursing Officer

An Oncology Certified Registered Nurse, Kristin has more than a decade of experience in helping cancer patients explore options and has personally guided thousands of patients through the clinical trial decision and enrollment process. Her role is to answer clinical questions and ensure patients have the support they need throughout their partnership with Massive Bio.

Stephanie Tran
Stephanie Tran
Chief Customer Delivery Manager

Stephanie drives new opportunities for providers and their patients, and delivers to our pharmaceutical clients. With extensive experience in patient recruitment, client relations, and business communications. She strives to bring clinical trial options to oncology practices, allowing providers to offer top-notch care and resources to their patients. She earned her Bachelor of Science degree in Public Relations and Communications from the University of Southern Indiana.

Fiona Evans
Fiona Evans
Lead Patient Advocate

Fiona works directly with patients to guide them through Massive Bio’s innovative cancer care, assisting them in identifying care needs and finding the right treatment options for their case. Fiona has spent the past 14 years working in the healthcare field, including cardiology, colon and rectal, surgery, and general medicine. Fiona’s history caring for patients in different settings has enabled her to evaluate medical concerns from a variety of perspectives.

Samantha Kingsbery
Samantha Kingsbery
Lead Clinical Research Nurse

Samantha is responsible for clinical trial matching and facilitating for the Virtual Tumor Board. Samantha has extensive experience in inpatient and outpatient medical oncology. She received her Bachelor of Science in Nursing from the University of Texas Medical Branch and a Bachelor of Science in Community Health from Texas A&M University. She is an Oncology Certified Nurse (OCN), committed to improving the quality of each patient’s cancer journey.

Josh Komins
Josh Komins
Marketing Specialist

Josh delivers marketing materials to patients directly and through Massive Bio’s social media pages. Josh creates informative and resourceful materials for cancer patients throughout the website and manages the Customer Relationship Management Software (CRM). Since graduating from West Virginia University with a degree in Marketing, Josh has learned about the cancer industry and has utilized and adapted to improve Massive Bio’s ability to help cancer patients.

Patient Advocates

Massive Bio’s patient advocate team has years of experience in supporting cancer patients and guiding them to make informed decisions about their individual case.

Jackie Bement
Jackie Bement
Patient Advocate

Jackie has years of experience serving and advocating for patients in the healthcare industry. She is dedicated to helping patients navigate Massive Bio’s cancer services as a devoted patient advocate. She works directly with patients to help them understand their cancer treatment options. She graduated from Elon University with a degree in biochemistry and is committed to helping advance the medical field through her work.

Board Members and Commercial Advisors

Primo Beadling

VP of Operations at IPB

Simin Zhou

Managing Director of UL Ventures

Paul Tanico

President at Castlerock Asset Management

Rina Sirinoglu

General Partner at 500 Startups

Kojo Appenteng

Managing Director

Gyan Kapur

Managing Director at Bayes Ventures

Scientific Advisory Board

Massive Bio’s scientific advisory board provides subject matter expertise as it relates to the current treatment practices for cancer and how they may be evolving. Our board evaluates:

  Current cancer treatment decisions on the selection of chemotherapy, backbones/biologics, and the sequencing of therapies based on recent data from world scientific meetings (ASCO, ESMO, AACR, etc.).
  Patient selection and approach towards personalized treatment with respect to tumor profiling and biomarker assessment.
  Economic analyses of cancer and how real world data (RWD) studies looking at effectiveness and costs would factor into treatment paradigms.
  The role of immunotherapy checkpoint inhibitors in cancer and other immune-oncology approaches in development.

Dr. Maurie Markman

A nationally renowned oncologist with experience in cancer treatment and gynecologic research at recognized facilities such as MD Anderson Cancer Center, the Cleveland Clinic and Memorial Sloan-Kettering Cancer Center. Dr. Markman received the esteemed American Society of Clinical Oncology (ASCO) Statesman Award. Dedicated to finding new and innovative ways to treat cancer, he has more than 1400 publications.

Dr. Stefan Glück
Dr. Stefan Glück

Dr. Stefan Glück leads early-stage development of solid tumors and immuno-oncology in a large pharmaceutical company. He was the Sylvester Professor at the Miller School of Medicine at the University of Miami, and the Clinical Director of the Braman Family Breast Cancer Institute. He was also Director, Southern Alberta Breast Cancer Program at the Tom Baker Cancer Center, and Deputy Head of the Department of Oncology at the University of Calgary.

Dr. Edgardo Santos
Dr. Edgardo Santos

Dr. Edgardo Santos practices at the Center for Hematology-Oncology (CHO), and is an Associate Professor of Clinical Biomedical Sciences at Florida Atlantic University, and Vice Chairman of the FLASCO Membership Committee. He earned is M.D. in 1994 at the University of Panama, School of Medicine, Republic of Panama. Dr. Santos completed fellowship in Hematology/Oncology at the Sylvester Comprehensive Cancer Center.


revo capital

Revo Capital

ipb logo

International Private Bank

ul logo

UL Ventures

500 Startups

Clinical Blockchain Data Science

Clinical Blockchain Data Science

Bayes Ventures

Bayes Ventures